ResearcherTel Aviv UniversityNo recent work listed
Raanan Berger
Matched on ORCID iD 0000-0002-2788-0971; OpenAlex author ID A5062199973. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 17
2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 5
- Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting. Co-author DOI 10.1158/2159-8290.cd-22-0412↗
- Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2021.01.220↗
- Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical models. Last author DOI 10.1002/ijc.31292↗
- Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease. Last author DOI 10.18632/oncotarget.17253↗
- Ascites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine. Last author DOI 10.1038/bjc.2014.123↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Talia Golan · 5 shared papers, 2014–2023 · strength 0.38
- Paper Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and … DOI 10.1158/2159-8290.cd-22-0412↗
- Paper Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2021.01.220↗
- Paper Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical models. DOI 10.1002/ijc.31292↗
- Chani Stossel · 4 shared papers, 2017–2023 · strength 0.33
- Paper Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and … DOI 10.1158/2159-8290.cd-22-0412↗
- Paper Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2021.01.220↗
- Paper Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical models. DOI 10.1002/ijc.31292↗
- Steve Gallinger · 4 shared papers, 2017–2023 · strength 0.33
- Paper Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and … DOI 10.1158/2159-8290.cd-22-0412↗
- Paper Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2021.01.220↗
- Paper Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical models. DOI 10.1002/ijc.31292↗
- Grainne Mary O'Kane · 2 shared papers, 2021–2023 · strength 0.22
- Paper Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and … DOI 10.1158/2159-8290.cd-22-0412↗
- Paper Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2021.01.220↗
- Faiyaz Notta · 2 shared papers, 2021–2023 · strength 0.22
- Paper Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and … DOI 10.1158/2159-8290.cd-22-0412↗
- Paper Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2021.01.220↗
- Spring Holter · 1 shared paper, 2021 · strength 0.09
- Sandra Elisabeth Fischer · 1 shared paper, 2021 · strength 0.09
- Ayelet Borgida · 1 shared paper, 2021 · strength 0.09
- Robert C. Grant · 1 shared paper, 2021 · strength 0.09
- Yifan Wang · 1 shared paper, 2021 · strength 0.09
- Hui‐Li Wong · 1 shared paper, 2021 · strength 0.09
- Jennifer Jane Knox · 1 shared paper, 2021 · strength 0.09
- David F. Schaeffer · 1 shared paper, 2021 · strength 0.09
- Daniel John Renouf · 1 shared paper, 2021 · strength 0.09
- George Zogopoulos · 1 shared paper, 2021 · strength 0.09
- Eitan Friedman · 1 shared paper, 2018 · strength 0.06
- Rotem Karni · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.